Citigroup Inc Heska Corp Transaction History

Citigroup Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$62.17 - $97.62 $80,821 - $126,906	-1,300 Reduced 16.09%	6,778 $661,000
Q4 2022 Feb 09, 2023	BUY	$60.21 - $77.74 $108,980 - $140,709	1,810 Added 28.88%	8,078 $502,000
Q3 2022 Nov 10, 2022	SELL	$72.92 - $99.73 $16,115 - $22,040	-221 Reduced 3.41%	6,268 $457,000
Q2 2022 Aug 10, 2022	SELL	$84.23 - $147.57 $390,742 - $684,577	-4,639 Reduced 41.69%	6,489 $613,000
Q1 2022 May 12, 2022	BUY	$122.89 - $171.74 $148,082 - $206,946	1,205 Added 12.14%	11,128 $1.54 Million
Q4 2021 Feb 10, 2022	BUY	$156.0 - $265.78 $569,556 - $970,362	3,651 Added 58.21%	9,923 $1.81 Million
Q3 2021 Nov 10, 2021	BUY	$228.69 - $274.2 $1.43 Million - $1.72 Million	6,272 New	6,272 $1.62 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.